Winner selected for potential of innovation to impact people with multiple sclerosis (MS) and their care partners [14-June-2019] NEW YORK , June 14, 2019 /PRNewswire/ -- Lyfebulb, a chronic disease-focused, patient-empowerment platform that connects patients with industry to support user-driven innovation, and Celgene Corporation (NASDAQ: CELG) announced that Kinza K
June 14, 2019
· 4 min read